Skarvan K, Schwinn W
Anaesthesist. 1986 Jan;35(1):17-23.
We studied the hemodynamic interaction between midazolam and alfentanil during induction of anaesthesia in 27 patients with coronary heart disease. Using alfentanil alone (93 +/- 6 micrograms/kg) the induction was associated with stable systemic haemodynamics but also with a pressure increase in pulmonary circulation, due to chest wall rigidity and respiratory acidosis. The administration of subhypnotic doses of midazolam (50 and 100 micrograms/kg) prior to alfentanil prevented chest wall rigidity and pulmonary vasoconstriction completely, suppressed the pressor response to intubation and reduced the dose of alfentanil required for induction. However the midazolam-alfentanil combination led to hypotension, which was primarily due to a decrease of peripheral systemic resistance. Thus the haemodynamic interaction between midazolam and alfentanil resembles the known interactions between other benzodiazepines and opiates, characterized by decreased sympathetic tone and suppressed baroreceptor reflex.
我们研究了27例冠心病患者麻醉诱导期间咪达唑仑与阿芬太尼之间的血流动力学相互作用。单独使用阿芬太尼(93±6微克/千克)诱导时,全身血流动力学稳定,但由于胸壁强直和呼吸性酸中毒,肺循环压力升高。在阿芬太尼之前给予亚催眠剂量的咪达唑仑(50和100微克/千克)可完全预防胸壁强直和肺血管收缩,抑制插管时的升压反应并减少诱导所需的阿芬太尼剂量。然而,咪达唑仑-阿芬太尼组合导致低血压,这主要是由于外周全身阻力降低。因此,咪达唑仑与阿芬太尼之间的血流动力学相互作用类似于其他苯二氮䓬类药物与阿片类药物之间已知的相互作用,其特征是交感神经张力降低和压力感受器反射受抑制。